Skip to content
OpenCapital
Get started

Harvard Bioscience HBIO Q3 2025 earnings

Reported November 6, 2025 · Before market open

Revenue$20.6MMiss by $2.5MDiluted EPS-$0.01Miss by $0.02
Revenue estimate$23.1M
EPS estimate$0.01

Next report

Aug 10, 2026 (In 4 weeks)
Revenue estimate$21.5M
EPS estimate-$0.21

Versus estimates

Revenue

Q1 2026$20.8MMiss by $445.0KQ4 2025$23.7MBeat by $635.0K
Q3 2025$20.6MMiss by $2.5M
Q2 2025$20.5MBeat by $1.5MQ1 2025$21.8MBeat by $374.0KQ4 2024$24.6MBeat by $3.6M

Diluted EPS

Q1 2026-$0.33Beat by $0.29Q4 2025-$0.01Miss by $0.36
Q3 2025-$0.01Miss by $0.02
Q2 2025-$0.01Beat by $0.02Q1 2025-$0.01Beat by $0.03Q4 2024$0.06Beat by $0.01

Ask the moment Harvard Bioscience reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Harvard Bioscience report Q3 2025 earnings?
Harvard Bioscience (HBIO) reported Q3 2025 earnings on November 6, 2025 before market open.
What were Harvard Bioscience's Q3 2025 revenue and EPS?
Harvard Bioscience reported revenue of $20.6M and diluted EPS of $-0.01 for Q3 2025.
Did Harvard Bioscience beat estimates in Q3 2025?
Revenue missed the consensus estimate of $23.1M by $2.5M. EPS missed the consensus estimate of $0.01 by $0.01.
How did Harvard Bioscience's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 6.3% from $22.0M a year earlier and diluted EPS grew 50.0% from $-0.02.
Where can I find Harvard Bioscience's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001171843-25-007071) and the 10-Q periodic report (0001171843-25-007099) directly on SEC EDGAR. The filing index links above go to sec.gov.